Managing Multiple Myeloma through Novel Immunotherapy Approaches: A Case Study In this case study, Nina Shah, MD, a UCSF hematologist oncologist who specializes in multiple myeloma immunotherapy, discusses a patient’s course of treatment, undertaken in collaboration with his local oncologist. When the patient’s disease recently progressed to clonal evolution, after nearly a decade of effective […]

Dr. Friedman on the Future of Selinexor in Multiple Myeloma Robb S. Friedman, MD, a hematologist and oncologist at Massachusetts General Hospital, discusses the future of selinexor (Xpovio) in multiple myeloma. Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive

Reasons & Treatment For Multiple Myeloma | Dr Sainath, Care Hospital | V6 Good Health #GoodHealth is a Featured Program on Health by V6, Today’s Program is about Reasons & Treatment For Multiple Myeloma. Dr Sainath From Care Hospital will give the solution to the callers’ questions. ఒక్క పోస్ట్ తో కాకా హోటల్ కు ఫుల్లు గిరాకీ..20 […]

Cellular Immunotherapy for the Treatment of Multiple Myeloma David Avigan, MD discusses how cellular immunotherapy can be used in treating multiple myeloma during the 2020 Dana-Farber Multiple Myeloma Patient Symposium.

Plasma cell neoplasms A comprehensive review of the diagnosis of plasma cell neoplasms. Presented by Dr. Fiona Craig, Mayo Clinic, Scottsdale, AZ Edited by Dr. Lori Soma Originally published 2/21/2017 This content is for educational purposes only. It is not intended to be a substitute for professional medical advice.

Dr. Usmani on Current Challenges in High-Risk Multiple Myeloma Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive

Multiple Myeloma in hindi – Pathophysiology , Clinical Features and Investigation|Plasma cell cancer Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Often, no symptoms are noticed initially. As it progresses, bone pain, anemia, kidney dysfunction, […]

Dr. Martin on Selinexor in Triple-Class Refractory Multiple Myeloma Thomas G. Martin, MD, clinical professor of medicine, Adult Leukemia and Bone Marrow Transplantation Program, associate director, Myeloma Program, University of California, San Francisco, and co-leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, discusses the use of selinexor in patients with triple-class refractory multiple […]

SARS-CoV-2 in multiple myeloma Multiple myeloma affects adaptive immunity with neoplastic plasma cells being unable to manufacture the polyclonal immunoglobulins required to fight infections. Additionally, myeloma treatment can raise immunodeficiency, especially during the initial months of treatment or during relapsed disease. In this video, Krina Patel, MD, MSc, MD Anderson Cancer Center, Houston, TX, talks […]

Multiple Myeloma – Closer to a Cure Community Lecture Series | Sarah Larson, MD, UCLA UCLA oncologist Sarah Larson, MD, covers the latest treatment options and clinical trials available to patients with myeloma. Learn more: https://www.uclahealth.org/closer-to-a-cure